These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21029044)

  • 1. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
    Chen S; Wan HY
    Biochem J; 2011 Jan; 433(2):277-84. PubMed ID: 21029044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
    Schmidt JJ; Stafford RG
    Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5.
    Guo J; Chan EW; Chen S
    Sci Rep; 2016 Jan; 6():19875. PubMed ID: 26794648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
    Chen S; Hall C; Barbieri JT
    J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
    Agarwal R; Binz T; Swaminathan S
    Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative characterization of botulinum neurotoxin subtypes F1 and F7 featuring differential substrate recognition and cleavage mechanisms.
    Guo J; Chan EW; Chen S
    Toxicon; 2016 Mar; 111():77-85. PubMed ID: 26748154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E.
    Chen S; Barbieri JT
    J Biol Chem; 2007 Aug; 282(35):25540-7. PubMed ID: 17609207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique substrate recognition mechanism of the botulinum neurotoxin D light chain.
    Guo J; Chen S
    J Biol Chem; 2013 Sep; 288(39):27881-7. PubMed ID: 23963459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
    Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
    Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
    Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
    Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.
    Agarwal R; Schmidt JJ; Stafford RG; Swaminathan S
    Nat Struct Mol Biol; 2009 Jul; 16(7):789-94. PubMed ID: 19543288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
    Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
    Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S; Barbieri JT
    J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
    Kalb SR; Baudys J; Raphael BH; Dykes JK; Lúquez C; Maslanka SE; Barr JR
    Anal Chem; 2015 Apr; 87(7):3911-7. PubMed ID: 25731972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
    Arndt JW; Yu W; Bi F; Stevens RC
    Biochemistry; 2005 Jul; 44(28):9574-80. PubMed ID: 16008342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.
    Masuyer G; Beard M; Cadd VA; Chaddock JA; Acharya KR
    J Struct Biol; 2011 Apr; 174(1):52-7. PubMed ID: 21078393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
    Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
    Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R; Rummel A; Binz T; Brunger AT
    Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.